|
"chuang wan long"的相關文件
顯示項目 76-100 / 104 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng; Yu, Ming-Lung; Kao, Jia-Horng; Tseng, Tai-Chung; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Liu, Chen-Hua; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Lu, Sheng-Nan; Liu, Chen-Hua; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Su, Wei-Wen; Lin, Chih-Lin; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study
|
Dai, Chia-Yen; Tseng, Tai-Chung; Wong, Grace Lai Hung; Huang, Jee-Fu; Wong, Vincent Wai Sun; Liu, Chun-Jen; Yu, Ming-Lung; Chuang, Wan-Long; Kao, Jia-Horng; Chan, Henry Lik Yuen; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2013 |
Pegylated Interferon-alpha 2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2013 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 嘉南藥理大學 |
2012-05 |
Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40]
|
Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 嘉南藥理大學 |
2012 |
Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin
|
Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung |
| 國立臺灣大學 |
2012 |
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
|
Liaw, Yun-Fan; Kao, Jia-Horng; Piratvisuth, Teerha; Chan, Henry Lik Yuen; Chien, Rong-Nan; Liu, Chun-Jen; Gane, Ed; Locarnini, Stephen; Lim, Seng-Gee; Han, Kwang-Hyub; Amarapurkar, Deepak; Cooksley, Graham; Jafri, Wasim; Mohamed, Rosmawati; Hou, Jin-Lin; Chuang, Wan-Long; Lesmana, Laurentius A.; Sollano, Jose D.; Suh, Dong-Jin; Omata, Masao; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2012 |
Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin
|
Yu, Ming-Lung; Liu, Chen-Hua; Huang, Chung-Feng; Tseng, Tai-Chung; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Kao, Jia-Horng; 劉振驊; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update (vol 6, pg 531, 2012)
|
Liaw, Yun-Fan; Kao, Jia-Horng; Piratvisuth, Teerha; Chan, Henry Lik Yuen; Chien, Rong-Nan; Liu, Chun-Jen; Gane, Ed; Locarnini, Stephen; Lim, Seng-Gee; Han, Kwang-Hyub; Amarapurkar, Deepak; Cooksley, Graham; Jafri, Wasim; Mohamed, Rosmawati; Hou, Jin-Lin; Chuang, Wan-Long; Lesmana, Laurentius A.; Sollano, Jose D.; Suh, Dong-Jin; Omata, Masao; 高嘉宏; 劉俊人 |
| 國立臺灣大學 |
2012 |
APASL consensus statements and management algorithms for hepatitis C virus infection
|
Omata, Masao; Kanda, Tatsuo; Yu, Ming-Lung; Yokosuka, Osamu; Lim, Seng-Gee; Jafri, Wasim; Tateishi, Ryosuke; Hamid, Saeed S.; Chuang, Wan-Long; Chutaputti, Anuchit; Wei, Lai; Sollano, Jose; Sarin, Shiv Kumar; Kao, Jia-Horng; McCaughan, Geoffrey W.; 高嘉宏 |
| 國立臺灣大學 |
2012 |
Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2011 |
Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
|
葉明倫; 洪肇宏; 劉俊人; 李全謨; 王景弘; 林子堯; 盧勝男; 胡琮輝; 余明隆; 高嘉宏; 莊萬龍; 陳培哲; 陳定信; YEH, MING-LUN; HUNG, CHAO-HUNG; LIU, CHUN-JEN; LEE, CHUAN-MO; WANG, JING-HOUNG; LIN, ZU-YAU; LU, SHENG-NAN; HU, TSUNG-HUI; YU, MING-LUNG; KAO, JIA-HORNG; CHUANG, WAN-LONG; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立臺灣大學 |
2009 |
Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up
|
劉俊人; 吳順生; 趙有誠; 楊賢馨; 林志陵; 高嘉宏; 劉振驊; 陳培哲; 陳定信; 莊萬龍; 李全謨; 余明隆; 盧勝男; LIU, CHUN-JEN; WU, SHUN-SHENG; CHAO, YOU- CHEN; YANG, SIEN-SING; LIN, CHIH-LIN; KAO, JIA-HORNG; LIU, CHEN-HUA; CHEN, PEI-JER; CHEN, DING-SHINN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN |
| 國立臺灣大學 |
2009 |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
劉俊人; 莊萬龍; 李全謨; 余明隆; 盧勝男; 吳順生; 陳祈玲; 楊賢馨; 高嘉宏; 劉振驊; 蘇維文; 鄭永銘; 陳培哲; 陳定信; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; CHEN, CHI-LING; YANG, SIEN-SING; KAO, JIA-HORNG; LIU, CHEN-HUA; SU, WEI-WEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立臺灣大學 |
2009 |
Analysis of Hbsag Levels in Patients Coinfected with Hepatitis B Virus and Hepatitis C Virus Treated with Peginterferon Alfa-2a and Ribavirin
|
陳建仁; 莊萬龍; 李全謨; 余明隆; 盧勝男; 吳順生; 廖麗瑛; 陳祈玲; 高嘉宏; 劉俊人; 鄭永銘; 陳培哲; 陳定信; CHEN, CHIEN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; LIAO, LI-YING; CHEN, CHI-LING; KAO, JIA-HORNG; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立臺灣大學 |
2008 |
An Open-Label, Comparative, Multicentre Study of Peginterferon Alfa-2a ( 40kd) Plus Ribavirin in the Treatment of Patients Chronically Infected with Hcv/Hbv or Hcv Alone
|
劉俊人; 莊萬龍; 李全謨; 吳順生; 廖麗瑛; 郭行道; 趙有誠; 陳祈玲; 陳培哲; 陳定信; LIU, CHUN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; WU, SHUN-SHENG; LIAO, LI-YING; KUO, HSING-TAO; CHAO, YOU-CHEN; CHEN, CHI-LING; CHEN, PEI-JER; CHEN, DING-SHINN |
| 國立成功大學 |
2007-09 |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sean D Sullivan; David L Veenstra; Chen, Pei-Jer; Chang, Ting-Tsung; Chuang, Wan-Long; Tsai, Chiaming; Patel, Kavita |
| 國立臺灣大學 |
2007 |
Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B E Antigen Positive Chronic Hepatitis B in Taiwan
|
陳培哲; 張定宗; 莊萬龍; CHEN, PEI-JER; CHANG, TING-TSUNG; CHUANG, WAN-LONG |
| 高雄醫學大學 |
2003 |
阻塞性輸尿管病變的大白鼠動物模式中 阻塞性輸尿管cytochrome c之釋放和肌細胞凋亡caspases相關蛋白的活化
|
莊豔凰;莊萬龍;黃書彬;黃俊雄 ; Chuang, Yen-Hwang;Chuang, Wan-Long;Huang, Shu-Pin;Huang , Chun-Hsiung |
| 高雄醫學大學 |
2002 |
細胞凋亡相關蛋白對阻塞性輸尿管平滑肌損傷之貢獻
|
莊艷凰;莊萬龍;黃書彬;黃俊雄 ; Chuang, Yen-Hwang;Chuang, Wan-Long;Huang, Shu-Pin;Huang , Chun-Hsiung |
| 高雄醫學大學 |
2002 |
凋亡相關蛋白的過度表現與阻塞性輸尿管肌肉損傷的關係(2002)
|
莊豔凰;莊萬龍;黃書彬;黃俊雄 ; Chuang, Yen-Hwang;Chuang, Wan-Long;Huang, Shu-Pin;Huang , Chun-Hsiung |
| 高雄醫學大學 |
2001 |
細胞凋零在阻塞性輸 尿管病變輸尿管損傷之致病機轉
|
莊艷凰;莊萬龍;黃俊雄 ; Chuang, Yen-Hwang;Chuang, Wan-Long;Huang , Chun-Hsiung |
顯示項目 76-100 / 104 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
